References
- Liedberg F, et al. Swedish guidelines on BC and UTUC. SJUN; in press.
- Babjuk M, Burger M, Capoun O, et al. European association of urology guidelines on non-muscle-invasive bladder cancer (ta, T1, and carcinoma in situ). Eur Urol. 2022;81(1):75–94.
- Gayhart MG, Johnson N, Paul A, et al. Universal mismatch repair protein screening in upper tract urothelial carcinoma. Am J Clin Pathol. 2020;154(6):792–801.
- Foy R, Skrypak M, Alderson S, et al. Revitalising audit and feedback to improve patient care. BMJ. 2020; 27:368:m213.
- Bobjer J, Hagberg O, Aljabery H, et al. A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancer. Scand J Urol. 2021; 55(2):108–115.
- Balar AV, Kamat AM, Kulkarni GS, et al. Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study. Lancet Oncol. 2021;22(7):919–930.
- Hendricksen K, A, Aziz P, Bes, et al. Discrepancy between European Association of Urology guidelines and daily practice in the management of non-muscle-invasive bladder cancer: results of a european survey. Eur Urol Focus. 2019;5(4):681–688.
- van Rhijn BWG, Hentschel AE, Bründl J, et al. Prognostic value of the WHO1973 and WHO2004/2016 classification systems for grade in primary ta/T1 non-muscle-invasive bladder cancer: a multicenter European Association of Urology non-muscle-invasive bladder cancer guidelines panel study. Eur Urol Oncol. 2021;4(2):182–191.
- Bobjer J, Hagberg O, Aljabery F, et al. Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study. Scand J Urol. 2022; 56(1):14–18.
- Sylvester RJ, Rodríguez O, Hernández V, et al. European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel. Eur Urol. 2021; 79(4):480–488.